NCT06051916

Brief Summary

Post operative urinary retention is a commonly observed complication following women undergoing urogynecology surgery. The trial includes patients undergoing bulking and vaginal prolapse surgery, who are randomized in two postoperative groups prior to surgery in order to test two void regimes. One group includes a strict voiding regime, where patients are discharged when voiding volume is minimum 150 ml and residual volume is maximum 200 ml. Comparatively, the minimalistic voiding group discharge patients after one spontaneous voiding, independent of voiding volume and residual volume. The primary aim of this study is to evaluate time to discharge in two different voiding trials techniques (strict vs minimalistic) after anterior, posterior or vaginal vault prolapse surgery as well as bulking surgery. Secondly, to register the development of postoperative urinary tract infection, urine retention, gynecological pain and patients' calls to the gynecological ward after discharge.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 25, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

April 4, 2024

Status Verified

April 1, 2024

Enrollment Period

1.9 years

First QC Date

September 18, 2023

Last Update Submit

April 2, 2024

Conditions

Keywords

surgerycomplication

Outcome Measures

Primary Outcomes (1)

  • Residual urine

    Residual urine after surgery

    12 hours postoperatively

Study Arms (2)

group B

ACTIVE COMPARATOR

Group B is the intervention group with minimalistic voiding trial. The patients in this group need to have one spontaneous voiding before discharge with the sensation of normal voiding, meaning there is no measurement of the voiding volume or residual volume.

Other: residual urine

Group A

NO INTERVENTION

Group A is the control group and presents the current procedures with strict voiding trial. The bladder is scanned before voiding to determine the bladder volume, and the voiding volume is measured. If the voiding volume is \>150 ml and the residual volume is \<200 ml, the patient can be discharged. If no acceptable residual volume is reached, the patient will be instructed in intermittent catheterization

Interventions

The study includes two group, A and B. Se previously

group B

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women who undergo anterior, posterior or vaginal vault prolapse surgery or bulking surgery at the departments of obstetric and gynecology, OUH.
  • Women who have the catheter removed at the operating room.
  • Women \>18 years old.

You may not qualify if:

  • Any surgery performed by due to malignancy
  • Previous cancer in the pelvic area
  • Previous radiation therapy in the pelvic area
  • Previous surgery in the pelvic area
  • Patients not understanding Danish
  • Patients with mental or similar illness
  • Patients with multiple sclerosis or diabetes type 1
  • Patients with late KAD removal based on per operative assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

martin Rudnicki

Odense C, Odense, 4300, Denmark

RECRUITING

Study Officials

  • Martin Rudnicki

    Odense Universitetshospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

martin Rudnicki, professor

CONTACT

Ulla Darling, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Group A receives a strict voiding trial and group B receives a minimalistic voiding trial. In both groups the patient's catheter is removed at the operation room before returning to the gynecological ward.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 18, 2023

First Posted

September 25, 2023

Study Start

November 1, 2023

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

April 4, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

no plan

Locations